This is a preview of subscription content, log in via an institution to check access.
References
Brown WA, Khan A. Which depressed patients should receive antidepressants? CNS Drugs 1994; 1: 341–7
Joyce PR, Paykel ES. Predictors of drug response in depression. Arch Gen Psychiatry 1989; 46: 89–99
American Psychiatric Association. Practice guidelines for major depressive disorder in adults. Am J Psychiatry 1993 Apr; 150 Suppl.: 1–26
Montgomery SA, Bebbington P, Cowen P, et al. Guidelines for treating depressive illness with antidepressants. A statement from the British Association for Psychopharmacology. J Psychopharmacol 1993; 7: 19–23
Kind P, Sorensen J. The costs of depression. Int Clin Psychopharmacol 1993; 7: 191–5
Jonsson B, Bebbington PE. What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment. Br J Psychiatry 1994; 164: 665–73
Reversible MAO-A inhibitors offer better tolerability than older antidepressants. Drug Ther Perspect 1994 Sep 19; 4: 12–14
Freemantle N, House A, Song F, et al. Prescribing of selective serotonin reuptake inhibitors as a strategy for prevention of suicide. BMJ 1994; 309: 249–53
Stewart A. Antidepressant pharmacotherapy: cost comparison of SSRIs and TCAs. Br J Med Econ 1994; 7: 67–79
Glassman AH, Stage KB. Depressed patients with cardiovascular disease. Treatment considerations. CNS Drugs 1994; 1: 435–40
Cantú TG, Korek JS, Romanoski AJ. Focus on venlafaxine. A new option for the treatment of depression. Hosp Form 1994; 29: 25–33
Rights and permissions
About this article
Cite this article
Tips for increasing antidepressant prescribing precision. Drugs Ther. Perspect 5, 10–12 (1995). https://doi.org/10.2165/00042310-199505040-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199505040-00004